Georgia State Researcher Gets $1.35 Million to Study Effects of Common Food Additive on Body

ATLANTA—Andrew Gewirtz, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a four-year, $1.35 million federal grant to study how emulsifiers affect bacteria in the intestinal tract and cause chronic inflammatory diseases in the gut.

Gewirtz will examine how the widely used food additive disturbs the relationship between the gastrointestinal… more »

Existing Anti-Stroke Drug Also Effective Treatment For Middle-Ear Infections, Researchers Say

ATLANTA—An existing anti-stroke drug is an effective treatment for middle-ear infections, showing the ability to suppress mucus overproduction, improve bacterial clearance and reduce hearing loss, according to researchers at Georgia State University and the University of Rochester.

The findings, published May 13 in the Journal of Immunology, could result in a novel, non-antibiotic treatment for… more »

Researchers Discover Why Drug For Severe COPD Becomes Less Effective In Patients Over Time

ATLANTA—Roflumilast, a drug recently approved in the United States to treat severe chronic obstructive pulmonary disease (COPD), increases the production of a protein that causes inflammation, which possibly results in patients developing a tolerance to the drug after repeated use and makes the drug less effective, according to researchers at Georgia State University, Kumamoto University… more »